Navigation Links
Life Sciences Leaders to Launch Statewide 'We Work for Health' Economic Development and Jobs Campaign

Group to Release Groundbreaking Study on Economic Impact of Life Sciences Sector on Washington State

SEATTLE, April 20 /PRNewswire/ -- An alliance of Washington state business, academic, government and community leaders will launch "We Work for Health," a landmark statewide effort to enhance the public's understanding of the economic impact of Washington's life sciences industry and to promote the growth and success of the sector.

We Work for Health will release the results of a groundbreaking study demonstrating the economic impact of the life sciences and biopharmaceutical sector in Washington state. The study will highlight the number of jobs created directly and indirectly by the biotechnology, biopharmaceutical, biomedical and research companies that make Washington an international hub for life sciences innovation.


News conference to launch We Work for Health, a statewide economic development and jobs advocacy coalition.

Release of job creation and economic impact study by Archstone Consulting of biopharmaceutical and related industries in Washington state.

Tour of Seattle Children's Research Institute to illustrate importance of life sciences jobs in Washington state.

    Thursday, April 23, 2009
    10 a.m. News Conference
    10:45 a.m. Tour of Seattle Children's Research Institute with President James B. Hendricks, PhD.

    Seattle Children's Research Institute
    Soundgarden Room, 11th floor
    1900 9th Ave.
    Seattle, WA 98101

Complimentary parking is available in the Diamond Parking garage in the Children's building. The entrance is located in the alley off Stewart Street between 9th and Terry.


We Work for Health Co-Chairs

  • Bob Drewel, Executive Director, Puget Sound Regional Council
  • Dr. Elson S. Floyd, President, Washington State University
  • Dr. Lee Huntsman, Executive Director, Life Sciences Discovery Fund
  • Chris Rivera, President, Washington Biotechnology and Biomedical Association
  • Rogers Weed, Director of the Washington State Department of Community, Trade and Economic Development


Michael Eckstut, Life Sciences Practice Leader, Archstone Consulting


We Work for Health is a statewide effort uniting organizations, companies, individuals and other stakeholders around a common goal: to educate policymakers and key opinion leaders about the economic impact of the life sciences innovation pipeline and to promote and grow the industry in Washington state. We Work for Health seeks to raise awareness of the impact of public policy on innovation in the life sciences, related industries and surrounding communities.

Media Contacts: Chelsea Waliser or Nate Cole-Daum, Nyhus Communications LLC for We Work for Health, (206) 323-3733 | or

SOURCE We Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caliper Life Sciences First Quarter 2009 Financial Results Conference Call Notice
2. Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson
3. HBO, UCSD Shiley-Marcos Alzheimers Disease Research Center, The Alzheimers Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMERS PROJECT: MOMENTUM IN SCIENCE
4. Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board
5. Advanced Life Sciences Announces Results of Shareholder Meeting and Provides Additional Information on Upcoming Advisory Committee Meeting
6. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
7. Derma Sciences Reports Fourth Quarter, Year-End Results for 2008
8. Human Pheromone Sciences Announces Fourth Quarter and Full Year Results
9. ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.
10. Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
11. Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood ... children and adults, according to a new study by researchers at the School of ... Children and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in ...
(Date:11/30/2015)... ... November 30, 2015 , ... Newly reviewed and approved “NJ Top ... from Tufts School of Dental Medicine in 1935. His father graduated from NYU ... being in dentistry as well as their commitment and passion to the Practice of ...
(Date:11/30/2015)... York, NY (PRWEB) , ... November 30, 2015 , ... ... York Times,” will be released on December 1, 2015, to coincide with World AIDS ... about the groundbreaking journalist who covered the AIDS epidemic as he was dying of ...
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for ... honor of World AIDS Day 2015. On Nov. 30, ASCP shared its “Give a ... about World AIDS Day and the importance of getting tested for HIV. , ASCP ...
(Date:11/30/2015)... ... 30, 2015 , ... California-based i2i Systems, a pioneer defining ... Michigan-based Family Health Center (FHC) has selected i2iTracks as their population health management ... the largest Affordable Care Act grant for Federally Qualified Health Centers in the ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  Kevin Smith ... Sensium Healthcare, a global pioneer in wireless monitoring ... Boston, MA , Mr. Smith will ... Sensium,s global commercial strategy.  He will also directly ... to build clinical evidence for SensiumVitals, the first ...
(Date:11/30/2015)... , Nov. 30, 2015  The fee-for-service ... in U.S. medical imaging is on its ... accountable care payer-provider contracts are set to ... their wake, alter provider-vendor relationships. The shift ... push forward new purchasing frameworks in the ...
(Date:11/30/2015)... WOODCLIFF LAKE, N.J. and SAN ... Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... (FDA) has accepted for filing the New Drug Application ... approved, the extended release formulation will offer patients a ... ® ) is currently approved as ...
Breaking Medicine Technology: